Association between illness perception and clinical control, quality of life, physical activity, and psychosocial status in subjects with moderate to severe asthma: a cluster analysis

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Citação
JOURNAL OF ASTHMA, v.60, n.1, p.115-122, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Illness perception (IP) is a psychosocial factor involved in several chronic diseases and is associated with relevant clinical outcomes. However, the relationship between IP and health-related quality of life (HRQoL), psychosocial status, and physical activity in daily life (PADL) in subjects with asthma is poorly understood.Objective: To identify groups of subjects with asthma based on their IPs and to assess their association with clinical control, HRQoL, psychosocial disturbances, and PADL.Methods: This cross-sectional study included 149 subjects with moderate to severe asthma. IP, anthropometric data, Asthma Control Questionnaire-7, Asthma Quality of Life Questionnaire, Hospital Anxiety and Depression Scale, PADL (accelerometry), and general self-efficacy (GSE) were assessed. Cluster analysis was performed to identify clusters with similar profiles and investigate their characteristics and differences. Pearson's correlation coefficient was used to test the associations between IP and other variables.Results: Statistical analyses identified two clusters of subjects with asthma based on IP. Cluster 1 presented worse IP in seven out of eight domains than Cluster 2. Cluster 1 had more negative consequences of the disease, worse understanding, and a high emotional representation of the disease than Cluster 2. Cluster 1 also had a greater extent of asthma symptoms, poor clinical control, worse HRQoL, and more symptoms of anxiety and depression. No difference between clusters was found for PADL or self-efficacy.Conclusion: Subjects with asthma who have worse IP have more negative symptoms, worse clinical control, HRQoL, and symptoms of anxiety and depression.
Palavras-chave
Asthma, illness perception, psychosocial factors, physical activity
Referências
  1. Angelini L, 2009, J BRAS PNEUMOL, V35, P618, DOI 10.1590/S1806-37132009000700002
  2. Bahçecioglu G, 2014, ACTA MEDICA MEDITERR, V30, P591
  3. Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004
  4. Bull Fiona C, 2020, Br J Sports Med, V54, P1451, DOI 10.1136/bjsports-2020-102955
  5. Cheng C, 2020, J NURS SCHOLARSHIP, V52, P145, DOI 10.1111/jnu.12540
  6. Cooley C, 2022, J ASTHMA, V59, P273, DOI 10.1080/02770903.2020.1847927
  7. Deshmukh VM, 2008, RESPIROLOGY, V13, P695, DOI 10.1111/j.1440-1843.2008.01310.x
  8. Figueiras MJ, 2015, PSYCHOL HEALTH MED, V20, P570, DOI 10.1080/13548506.2014.993662
  9. Freitas PD, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.00240-2020
  10. Freitas PD, 2018, MED SCI SPORT EXER, V50, P1367, DOI 10.1249/MSS.0000000000001574
  11. Global Initiative for Asthma (GINA), 2016, GLOB STRAT ASTHM MAN
  12. Global Initiatives for Asthma, 2020, Global Strategy for asthma management and prevention
  13. Hagger MS, 2017, PSYCHOL BULL, V143, P1117, DOI 10.1037/bul0000118
  14. Hansen ESH, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00146-2020
  15. Harrison SL, 2014, RESP MED, V108, P319, DOI 10.1016/j.rmed.2013.10.016
  16. Juniper EF, 2006, RESP MED, V100, P616, DOI 10.1016/j.rmed.2005.08.012
  17. Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x
  18. JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76
  19. Kosse RC, 2020, J ASTHMA, V57, P1145, DOI 10.1080/02770903.2019.1635153
  20. Leite Mylene, 2008, J. bras. pneumol., V34, P756, DOI 10.1590/S1806-37132008001000002
  21. Leventhal H, 2016, J BEHAV MED, V39, P935, DOI 10.1007/s10865-016-9782-2
  22. Lopes AC, 2019, CHRONIC ILLN, V15, P138, DOI 10.1177/1742395317753883
  23. Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
  24. Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494
  25. Nunes R., 1999, PERCEIVED GEN SELF E
  26. Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008
  27. Pignataro FS, 2017, PHARMACOL RES, V119, P384, DOI 10.1016/j.phrs.2017.02.017
  28. Pinnock H, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0823-7
  29. Reid H, 2022, BRIT J SPORT MED, V56, P427, DOI 10.1136/bjsports-2021-104281
  30. Richardson EM, 2017, PSYCHO-ONCOLOGY, V26, P724, DOI 10.1002/pon.4213
  31. Scharloo M, 1998, J PSYCHOSOM RES, V44, P573, DOI 10.1016/S0022-3999(97)00254-7
  32. Schwarzer R., 1995, Measures in health psychology: a user's portfolio, causal and control beliefs, P35, DOI [10.1037/t00393-000, DOI 10.1037/T00393-000]
  33. Skinner TC, 2011, PSYCHOL HEALTH, V26, P321, DOI 10.1080/08870440903411039
  34. Steele BG, 2000, CHEST, V117, P1359, DOI 10.1378/chest.117.5.1359
  35. Szabo-Bartha Anett, 2021, Psychiatr Danub, V33, P432
  36. Tran L, 2021, J ASTHMA, V58, P759, DOI 10.1080/02770903.2020.1731826
  37. Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-80
  38. Xu M, 2021, J ASTHMA, V58, P1426, DOI 10.1080/02770903.2020.1810273
  39. ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x